Newsletter The Women’s Health Activist® is a bimonthly publication of the National Women’s Health Network. We’d like to hear from you. Please e-mail questions or comments to email@example.com.
At the intersection of abortion rights and anti-choice: A quiet street corner exemplifies an intense dispute
By Iliana Kiourkas
By Jane Zones, Ph.D.
For 40 years, control over one’s body has been a fundamental principle of the women’s health movement. We have fought and won many battles to preserve our right to make decisions about our own health and well-being. But over the last two decades, various corporations and institutions have secured patent protection on about 20 percent of the approximately 30,000 genes that make up the human genome.
By Rachel Walden
By Tracy Weitz, PhD, MPA
By Cynthia Pearson, Exective Director
By Elizabeth Miller, MD, PhD
By Jill Battalen, Director of Individual Giving
By Margaret Conway, Lydia Stuckey and Kirsten Moore
By D'Laura Brumfield
By Charlea T. Massion, MD & Adriane Fugh-Berman, MD
In mid-July, a Food and Drug Administration (FDA) advisory committee voted to keep the diabetes drug Avandia (rosiglitazone) on the market, while simultaneously acknowledging not only that the drug increases the risk of heart attacks, but also that there are many other, safer medications available — including Actos (pioglitazone), a close sibling of Avandia made by a competing manufacturer.
By Amy Allina, NWHN Policy Director
By Natieka Samuels
In the last NWHN Board of Directors elections, all three incumbents were re-elected: Bindiya Patel, Laura Kaplan and Susan Wood. In addition, three members will join the board in June: Priscilla Huang, Charlea Massion, and Zipatly Mendoza. Learn more about these excellent women in their candidate’s statements, below:
By Nekose Wills
By Cynthia Pearson
By Gina Smith